Concourse Financial Group Securities, Inc. Cellectis S.A. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$1.9 - $2.4 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$1.86 - $3.35 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$2.41 - $3.09 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$0.97 - $3.55 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$1.58 - $2.86 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$1.58 - $2.86 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$1.72 - $2.12 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$1.83 - $3.84 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$1.85 - $2.6 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$2.29 - $4.08 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$2.39 - $4.93 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$3.45 - $8.77 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$8.01 - $12.84 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	SELL	$11.94 - $16.09 $32,524 - $43,829	-2,724 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$14.36 - $20.93 $20,620 - $30,055	-1,436 Reduced 34.52%	2,724 $42,000
Q1 2021 May 13, 2021	BUY	$18.19 - $33.25 $8,876 - $16,226	488 Added 13.29%	4,160 $84,000
Q4 2020 Feb 02, 2021	BUY	$15.87 - $31.64 $6,681 - $13,320	421 Added 12.95%	3,672 $99,000
Q3 2020 Nov 13, 2020	BUY	$15.7 - $20.84 $3,202 - $4,251	204 Added 6.7%	3,251 $60,000
Q2 2020 Aug 13, 2020	BUY	$8.21 - $21.02 $1,535 - $3,930	187 Added 6.54%	3,047 $54,000
Q1 2020 May 13, 2020	BUY	$7.81 - $18.82 $101 - $244	13 Added 0.46%	2,860 $26,000
Q4 2019 Feb 14, 2020	BUY	$9.73 - $19.31 $11,714 - $23,249	1,204 Added 73.28%	2,847 $49,000
Q3 2019 Nov 13, 2019	BUY	$10.15 - $16.89 $9,825 - $16,349	968 Added 143.41%	1,643 $17,000
Q2 2019 Aug 13, 2019	BUY	$14.6 - $20.6 $7,606 - $10,732	521 Added 338.31%	675 $11,000
Q1 2019 May 15, 2019	BUY	$15.53 - $19.75 $2,391 - $3,041	154 New	154 $2,000
Q4 2018 Feb 14, 2019	BUY	$15.58 - $28.41 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$25.99 - $30.6 $0 - $0	0 New	0 $0

Others Institutions Holding CLLS

# of Institutions

Shares Held

11.2M

Call Options Held

5.9K

Put Options Held

1.4K

Long Focus Capital Management, LLC San Juan, PR

4.62M
Shares

$8.63 Million
0.36% of portfolio
Capital International Investors Los Angeles, CA

1.85M
Shares

$3.46 Million
0.0% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

1.44M
Shares

$2.69 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.44M
Shares

$2.69 Million
0.0% of portfolio
Baillie Gifford & CO

694K
Shares

$1.3 Million
0.0% of portfolio

View Full List

About Cellectis S.A.

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $85.1M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

More about CLLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account